Biomedical Research and Longevity … - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1977

Legal Domicile

Principal Officer

Jeffrey Moskovitz

Phone

9547668433

Tax Period

2025-01-01 to 2025-12-31

Biomedical Research and Longevity Society Inc, founded in 1977, is a mid-sized nonprofit in the Science & Technology sector that reported $10.4M in total revenue in fiscal year 2025. Revenue surged 21% from the prior year, signaling strong growth momentum. The organization ran a surplus of $1.7M, a strong 16% operating margin.

Mission

To fund and support scientific research and education for the benefit of all humankind with a focus on cryobiology interventive gerontology and cryonics.

Program Service Accomplishments

Program 1

Expenses: $8,420,019 Revenue: $0

The organization provides grants and other support to scientific research institutions for the purpose of advancing research and education in the area of preservation storage and restoration of...

The organization provides grants and other support to scientific research institutions for the purpose of advancing research and education in the area of preservation storage and restoration of biological tissue.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2025)

Revenue Breakdown

Contributions & Grants $25,150

Program Service Revenue $0

Investment Income $2,849,427

Other Revenue $7,491,326

TOTAL REVENUE $10,365,903

Expense Breakdown

Grants Paid $8,099,391

Salaries & Benefits $243,334

Fundraising Expenses $0

Program Expenses $8,420,019

Other Expenses $332,017

TOTAL EXPENSES $8,674,742

Year-over-Year Comparison

	2025	2024	Change
Revenue	$10,365,903	$8,573,555	+0.2%
Expenses	$8,674,742	$8,343,449	+0.0%
Net Income	$1,691,161	$230,106	+6.3%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$131,143

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Jeffrey Moskovitz	President	45.00	Officer	$131,143	$0	$131,143
Kevin Brown PhD	Director	4.00	Director	$0	$0	$0
James W Clement JD LLM PhD	Director	4.00	Director	$0	$0	$0
Austin Day PhD	Director	4.00	Director	$0	$0	$0
William J Faloon	Director	4.00	Director	$0	$0	$0
Rodolfo G Goya PhD	Director	4.00	Director	$0	$0	$0
Rudi Hoffman	Director	4.00	Director	$0	$0	$0
Dennis Mathew	Director	4.00	Director	$0	$0	$0
Carrie Radomski	Director	4.00	Director	$0	$0	$0
Bruce Waugh JD	Director	4.00	Director	$0	$0	$0
Nicholas R Vandermeulen	Vice President	4.00	Officer	$0	$0	$0
David Greenstein	Secretary Treasurer	4.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$10,365,903	$8,674,742	$54,572,370	$1,691,161
2024	$8,573,555	$8,343,449	$44,581,646	$230,106
2023	$10,215,186	$7,897,460	$42,897,848	$2,317,726
2022	$8,025,921	$7,319,855	$40,256,584	$706,066
2021	$8,171,576	$5,915,966	$38,493,500	$2,255,610
2020	$9,085,401	$5,324,622	$37,530,334	$3,760,779
2019	$6,870,583	$6,159,523	$29,588,137	$711,060
2018	$5,869,377	$11,481,991	$26,708,608	$-5,612,614
2017	$5,833,280	$8,624,925	$29,946,651	$-2,791,645

Biomedical Research and Longevity Society Inc